Company News

MENAFN.com reported that Teva Pharmaceutical Industries Ltd (NYSE:TEVA) has acquired all of MicroDose Therapeutx’s outstanding shares for US$40 million.

MENAFN.com reported that Teva Pharmaceutical Industries Ltd (NYSE:TEVA) has acquired all of MicroDose Therapeutx’s outstanding shares for US$40 million.

As quoted in the market news:

MicroDose Therapeutx will receive additional payments of up to USD125m upon achievement of regulatory and development milestones, plus sales-based milestones and tiered royalty payments upon commercialisation of MDT-637 and an earlier stage Asthma/COPD medicine.

A drug delivery company, MicroDose Therapeutx is focused on inhalation technologies and products for lung diseases and infections with the potential to dramatically improve efficacy and patient compliance.

Click here for the full news story by MENAFN.com

MARKETS

Markets
TSX19620.13+43.09
TSXV664.17+4.09
DOW32803.47+76.65
S&P 5004145.19-6.75
NASD12657.55-63.03
ASX7015.60+40.70

COMMODITIES

Commodities
Gold1774.96+1.14
Silver19.90+0.01
Copper3.55+0.07
Palladium2124.59+12.40
Platinum936.51+2.50
Oil88.53-0.01
Heating Oil3.20-0.13
Natural Gas8.01-0.12

DOWNLOAD FREE REPORTS

×